Table 3 Proportion of low and high activation level respondents with reported change in measured PAM-13 domains
Patient’s activation level | χ2(DF), p | |||
|---|---|---|---|---|
Low level of activation (PAM-13 levels 1 and 2, n = 46) | High level of activation (PAM-13 levels 3 and 4, n = 96) | |||
Increased assistance with ADL | No | 58.7% | 83.2% | χ2 (1) = 9.94, p = 0.002 |
Yes | 41.3% | 16.8% | ||
Worsening of disease symptoms | No | 40% | 63.8% | χ2 (1) = 7.02, p = 0.008 |
Yes | 60% | 36.2% | ||
Increased tiredness | No | 33.3% | 67% | χ2 (1) = 14.02 P < 0.001 |
Yes | 66.7% | 33% | ||
Lack of family members’ and friends’ support | No | 30.4% | 63.5% | χ2 (1) = 13.68 p < 0.001 |
Yes | 69.6% | 36.5% | ||